Extendicare Inc. · TSX:EXE

Extendicare — Investor Presentation (November 2026)

21 slides from Extendicare's investor presentation, November 2026

  1. Slide 1: Growing Together – Investor Presentation

    Growing Together Investor Presentation November 2026

  2. Slide 2: Cautionary statement

    Cautionary statement Forward-looking Statements results and developments discussed in the forward-looking evaluate the performance of the Company. The terms “EBITDA”, statements, as they are subject to a number of risks and “Adjusted EBITDA”, “net operating income” (“NOI”), “normalized This presenta

  3. Slide 3: Extendicare (TSX: EXE)

    Extendicare (TSX: EXE) Canada’s largest seniors’ care provider focused on long-term care and home health care • Strong growth opportunities: Organic growth driven by 58 years of providing demographic trends augmented by deep acquisition seniors’ care pipeline in a fragmented Canadian market • Indust

  4. Slide 4: Services-focused growth

    Services-focused growth Business model enables growth without significant capital requirements Direct care for seniors NOI contribution by segment(1) Home health care Long-term care TTM Q3 2026 NOI(1) $299.0M Managed Home health care ~28M Home 57 services health care Long-term care 1 $149.7M 50.1% $

  5. Slide 5: Meeting the needs of a growing demographic

    Meeting the needs of a growing demographic Compelling growth in long-term care and home health care Building new LTC homes to address the rising demand for long-term care Canadian population aged 85+ 3x • Seniors aged 85+ increasing at ~4% per year(1) 3.0 • LTC waitlist of more than 51,000(2) in Ont

  6. Slide 6: Ontario LTC beds per 1,000 people aged 75+

    Ontario LTC beds per 1,000 people aged 75+ Development activity has not kept up with growing demand; home health care bridges the gap • From 1996 to 2006, over 23,000 LTC beds Ontario LTC beds per 1,000 people over 75 were added in Ontario, reaching a high of 100 99 beds per 1,000 Ontarians aged 75+

  7. Slide 7: Home health care

    Home health care Strong volume and NOI growth supported by investments in training, recruiting programs and technology; highly fragmented market offers M&A opportunities • Robust demand for home health care services driven by Home Health Care NOI & NOI Margins(1)(2) aging Canadian population, strain

  8. Slide 8: Home Health acquisitions continue to perform

    Home Health acquisitions continue to perform CBI Home Health Adjusted EBITDA ~23% ahead of announcement pro forma; CTG integration substantially complete • Annualized CBI Adjusted EBITDA is ~23% ahead of $597M $478M underwritten pro forma Adjusted EBITDA Revenue(1) +25% Revenue(3) (Annualized Q2- (T

  9. Slide 9: Workday + AlayaCare Power ParaMed Care Delivery

    Workday + AlayaCare Power ParaMed Care Delivery Technology-enabled business processes create a highly scalable homecare growth platform Patients are referred by Based on assessment, AlayaCare is leveraged Each patient is assessed hospitals and doctors to the government agency to build efficient Clin

  10. Slide 10: Home Health Care Market Environment

    Home Health Care Market Environment National platform delivering various home health care services in a stable contract environment Assistance with activities of daily Provincial Contracts living provided by PSWs including: Personal Support Services • Personal hygiene Ontario Alberta Nova Scotia • S

  11. Slide 11: Long-term care

    Long-term care Industry-leading scale and strong operating performance drive stable NOI growth LTC NOI & NOI Margins(1)(2) 11.8% $120M 10.9% 12% 10.4% • LTC segment has returned to pre-pandemic occupancy $100M 8.4% 10% and NOI $80M 8% $60M 6% • Extendicare operates 57 fully owned LTC homes $40M 4% •

  12. Slide 12: Building for the future

    Building for the future Progressed redevelopment program in 2026: opened two new homes, sold Sudbury project into the Axium JV; and sold vacated Peterborough Class C home Forest Trail Upgrading our portfolio quality, driving management fee growth Five LTC homes (1,152 new beds) under construction in

  13. Slide 13: Joint Venture with Axium Infrastructure

    Joint Venture with Axium Infrastructure Funds LTC redevelopment and expansion, driving revenue growth in Managed Services Extendicare Sell Project to JV Identify Project Develop Project Manage Operations Manage Recycle Capital Sell project to JV, with Construction & Pipeline of 17 Acquire land, reim

  14. Slide 14: Managed services | Extendicare Assist and SGP

    Managed services | Extendicare Assist and SGP Growth in SGP purchasing clients and new homes in the Axium JV drive NOI growth Managed Services NOI and NOI Margins(1) • Highest margin segment, focused on expanding service $45M 70% 53.5% 55.0% 55.8% 52.5% 60% offerings and geographic reach $30M 50% •

  15. Slide 15: Strong liquidity and credit metrics

    Strong liquidity and credit metrics Pro forma Debt to Adjusted EBITDA improved to ~2.3x; ~$246M of available liquidity provides significant flexibility for capital allocation Debt Metrics(1)(3)(4) 10.2x As at September 30, 2026 10.0x 37.0% 7.9x 32.5% Available 31.4% Long-term Weighted Average 26.0%

  16. Slide 16: Appendix

    Appendix Extendicare

  17. Slide 17: Senior unsecured BBB credit structure established in Q2

    Senior unsecured BBB credit structure established in Q2 Weighted average interest rate down 80bps and average maturity increased to 5.1 years Consolidated Debt Pro Forma Consolidated Debt As at September 30, 2026 As at March 31, 2026 Year of September 30, Year of Pro Forma ('000s, unless otherwise n

  18. Slide 18: Reconciliation of Net Earnings to Adjusted Net Earnings

    Reconciliation of Net Earnings to Adjusted Net Earnings Years ended December 31, 2023, 2024, and 2025, and twelve months ended September 30, 2026 FY FY FY TTM Q3 2023 2024 2025 2026 “Adjusted net earnings” is defined as net earnings (loss), excluding the following line items: “amortization of acquir

  19. Slide 19: Impact of out-of-period items

    Impact of out-of-period items Years ended December 31, 2023, 2024, and 2025, and twelve months ended September 30, 2026 • 2023 results impacted by COVID-19 related funding and costs and other out-of-period items o Home health care recognized $1.0M of COVID-19 related funding and costs Impact of out-

  20. Slide 20: Financial Summary

    Financial Summary Years ended December 31, 2023, 2024, and 2025, and twelve months ended September 30, 2026 Select Annual and TTM Q3-26 Information FY 2023 margin FY 2024 margin FY 2025 margin TTM Q3 2026 margin Revenue $1,305.0M $1,466.2M $1,660.4M $2,166.1M Home health care $469.1M $566.0M $701.1M

  21. Slide 21: Helping people live better

    Helping people live better

Extendicare — Investor Presentation (November 2026) on 6ix